Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Fairfax Completes US$900,000,000 Senior Notes Offering
-
Mattr Reports Voting Results From Annual Meeting
-
Vaxart, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
-
Helium Evolution Announces Filing of First Quarter 2025 Financial Results
-
Latin Metals Announces Closing of Oversubscribed Private Placement for Gross Proceeds of $1.33 Million
-
Segra International Acquires Klonetics to Expand Nursery Capacity and Accelerate Growth
-
First Busey Corporation Closes Depositary Share Offering
-
Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
-
Global Alzheimer’s Platform Foundation Applauds FDA Authorization of the First Blood-Based Diagnostic Test for Assessing Alzheimer’s Disease
-
JOSTENS® EPIC SCHOOL REVAMP™ CONTEST HOLDS 2nd ANNUAL REVEAL
-
XRP News: Vaultro Finance Presale Gains Investor Attention as It’s Index Fund Protocol Interface Goes Live!
-
Northrop Grumman Increases Quarterly Dividend 12 Percent to $2.31
-
TrialWire the AI and Algorithm-powered Platform Named a Fierce CRO Award Finalist in the “Outstanding Patient Recruitment and Retention” Category
-
Northrop Grumman Increases Quarterly Dividend 12 Percent to $2.31
-
Golar LNG Limited: 2025 AGM Results Notification
-
Meritage Homes Extends Partnership with Operation Homefront, Donating Two Mortgage-Free Homes to Military Families in Colorado and North Carolina
-
Plantro Ltd. Increases Purchase Price under All-Cash Tender Offer to Acquire Class A Shares of Information Services Corporation to $30 per Class A Share
-
Hyperscale Data Declares Monthly Cash Dividend of $0.2708333 Per Share of 13.00% Series D Cumulative Redeemable Perpetual Preferred Stock
-
F&M Bank Announces Resignation of Board Member Jo Ellen Hornish
-
CubeSmart Declares Second Quarter 2025 Dividend
-
Toll Brothers Reports FY 2025 Second Quarter Results
-
Fitch Ratings Agency Upgrades Teva Rating to BB+ Recognizing Successful Execution of Its Pivot to Growth Strategy
-
Valley National Bancorp Declares Its Regular Quarterly Preferred and Common Stock Dividends
-
Neuphoria Provides First Quarter 2025 Business Updates
-
Vishay Intertechnology Declares Quarterly Dividend
-
XWELL Reports First Quarter 2025 Results, Advancing Mission to Liberate Science-Proven Wellness
-
TEGNA Announces Quarterly Dividend
-
NBT Bancorp Inc. Announces Cash Dividend
-
Americold Realty Trust, Inc. Declares Second Quarter 2025 Dividend
-
CooperCompanies’ 2024 Sustainability Report Showcases Efforts that Benefit People and the Planet
-
Mesa Air Group Reports Second Quarter Fiscal 2025 Results
-
ESCO Announces Divestiture of VACCO Industries
-
Talonvest Negotiates $51,317,000 Acquisition Loan for Texas Storage Portfolio
-
Verisk Welcomes Christopher Perry and Sabra Purtill to its Board of Directors
-
RxSight, Inc. to Participate in the Stifel 2025 Virtual Ophthalmology Forum
-
Carlyle Credit Income Fund Announces Second Quarter Financial Results and Declares Monthly Common and Preferred Dividends
-
GENFIT to receive a €26.5 million milestone payment following the approval of pricing and reimbursement of Ipsen’s Iqirvo® in Italy
-
PCI BIotech: Disclosure of voting rights for Chair of the Board
-
DBM Global Enters Into an Amended and Restated Credit Agreement
-
INROADS Names Ron Houston as New President and CEO to Drive the Organization’s Next Chapter of Growth and Impact
-
DBM Global Enters Into Amended and Restated Credit Agreement
-
POET Technologies Announces Upsize and Amendments to Previously Announced Offering
-
Top KingWin Ltd Regains Compliance with Nasdaq Minimum Closing Bid Price Rule
-
INVO Fertility Announces First Quarter 2025 Financial Results
-
Westrock Coffee Company to Participate in TD Cowen's' 9th Annual Future of the Consumer Conference
-
Viasat Releases Fourth Quarter and Fiscal Year 2025 Financial Results
-
Stitch Fix Announces Date for Third Quarter 2025 Financial Results and Conference Call
-
Sportsman's Warehouse Holdings, Inc. Schedules First Quarter 2025 Earnings Conference Call
-
Soleno Therapeutics Announces Data Presentation Showing that Resumption of Treatment with VYKAT(TM) XR after a Randomized Withdrawal Period was Associated with Significant Improvements in Hyperphagia
-
Prairie Band Casino & Resort Transitions from Viz Explorer to Quick Custom Intelligence’s (QCI) Enterprise Platform

